Molecular Partners AG
SIX:MOLN

Watchlist Manager
Molecular Partners AG Logo
Molecular Partners AG
SIX:MOLN
Watchlist
Price: 5.2 CHF 1.96% Market Closed
Market Cap: 191.6m CHF
Have any thoughts about
Molecular Partners AG?
Write Note

Molecular Partners AG
Total Liabilities & Equity

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Molecular Partners AG
Total Liabilities & Equity Peer Comparison

Comparables:
ADCT
ACIU
CRSP
BSLN
KURN

Competitive Total Liabilities & Equity Analysis
Latest Figures & CAGR of Competitors

Company Total Liabilities & Equity CAGR 3Y CAGR 5Y CAGR 10Y
Molecular Partners AG
SIX:MOLN
Total Liabilities & Equity
CHf170.6m
CAGR 3-Years
-6%
CAGR 5-Years
5%
CAGR 10-Years
N/A
ADC Therapeutics SA
NYSE:ADCT
Total Liabilities & Equity
$354.8m
CAGR 3-Years
-12%
CAGR 5-Years
19%
CAGR 10-Years
N/A
AC Immune SA
NASDAQ:ACIU
Total Liabilities & Equity
CHf237.5m
CAGR 3-Years
4%
CAGR 5-Years
-4%
CAGR 10-Years
N/A
CRISPR Therapeutics AG
NASDAQ:CRSP
Total Liabilities & Equity
$2.3B
CAGR 3-Years
-7%
CAGR 5-Years
26%
CAGR 10-Years
N/A
Basilea Pharmaceutica AG
SIX:BSLN
Total Liabilities & Equity
CHf188.7m
CAGR 3-Years
-6%
CAGR 5-Years
-4%
CAGR 10-Years
-4%
Kuros Biosciences AG
SIX:KURN
Total Liabilities & Equity
CHf77.3m
CAGR 3-Years
-6%
CAGR 5-Years
-1%
CAGR 10-Years
N/A

See Also

What is Molecular Partners AG's Total Liabilities & Equity?
Total Liabilities & Equity
170.6m CHF

Based on the financial report for Jun 30, 2024, Molecular Partners AG's Total Liabilities & Equity amounts to 170.6m CHF.

What is Molecular Partners AG's Total Liabilities & Equity growth rate?
Total Liabilities & Equity CAGR 5Y
5%

Over the last year, the Total Liabilities & Equity growth was -26%. The average annual Total Liabilities & Equity growth rates for Molecular Partners AG have been -6% over the past three years , 5% over the past five years .

Back to Top